METASTATIC HORMONE-SENSITIVE PROSTATE CANCER

This study is testing a new long-acting injectable drug, ASP5541, for men with advanced prostate cancer. It aims to see how the drug moves through the body and if it is safe when given alongside standard hormone therapy and a steroid. The study will enroll 12 Chinese men who will…

This study is testing a new injectable form of a prostate cancer hormone therapy called ASP5541. It aims to see if this injection, given every 12 weeks, works as well or better than the standard daily pill version and if it causes fewer side effects. The trial will enroll about 2…

This study is monitoring the safety of darolutamide, an already approved prostate cancer medication, in 600 Korean patients. Researchers will track side effects and see how well the drug works over time by reviewing patients' medical records during their regular doctor visits. Th…

This study is testing whether adding a new experimental drug, JSB462, to standard hormone therapy works better and is safe for men whose prostate cancer has spread but still responds to hormone treatment. It will involve about 150 men and compare the new combination against curre…

This early-stage study is testing a new drug, JNJ-78278343, that aims to guide the body's own immune cells to attack prostate cancer. It is being given in combination with other standard treatments like immunotherapy, chemotherapy, or hormone therapy. The main goals are to find a…

This study is testing a new radioactive drug called [²¹²Pb]Pb-ADVC001 for men with prostate cancer that has spread. The first part aims to find the safest and most effective dose. The second part will see how well that dose works to control the cancer in different groups of patie…

This study aims to understand how well men with advanced prostate cancer stick to their prescribed medication, apalutamide, during the first year of treatment. Researchers will follow 270 patients in France to see who takes their pills as directed and explore the personal, social…

This study aims to understand how doctors use the drug darolutamide in real-world clinics to treat men with metastatic prostate cancer that has spread at diagnosis. Researchers will look back at the medical records of about 1,400 men to see who gets the drug, how they take it, an…